Aurinia Pharmaceuticals Inc.

AUPHNASDAQHealthcare● Active

$16.15

+$0.31(+1.96%)

Market Cap$2.1B

P/E Ratio—

52W High$16.88

52W Low$7.285

Avg Volume1.2M

Open$16.06

Beta1.43

Overview

Aurinia Pharmaceuticals Inc. (AUPH) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · AUPH · as of Feb 26, 2026

Latest filing snapshot

128

-2-1.54%vs prior year

Aurinia Pharmaceuticals Inc. (AUPH) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

128

Change (1Y)

-2

Growth % (1Y)

-1.54%

Revenue / Employee

$2.21M

Net Income / Employee

$2.24M

Market Cap

$2.1B

AUPH Employee Count

2014 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-26	2025-12-31	128	-2	-1.54%
2025-02-27	2024-12-31	130	-170	-56.67%
2024-02-15	2023-12-31	300	+0	+0.00%
2023-02-28	2022-12-31	300	+0	+0.00%
2022-02-28	2021-12-31	300	+6	+2.04%
2021-02-24	2020-12-31	294	+294	—
2020-03-05	2019-12-31	0	+0	—
2019-03-19	2018-12-31	0	+0	—
2018-03-15	2017-12-31	0	+0	—
2017-03-09	2016-12-31	0	+0	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ABCL

AbCellera Biologics Inc.

596$1.7B #2

IMCR

Immunocore Holdings plc

493$1.4B #3

HRMY

Harmony Biosciences Holdings, Inc.

Celldex Therapeutics, Inc.

186$1.9B #6

AUPH

Aurinia Pharmaceuticals Inc.YOU

128$2.1B #7

JANX

Janux Therapeutics, Inc.

91$815M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · AUPH peer comparison

About AUPH employees

AUPH Employees · Headcount

Aurinia Pharmaceuticals Inc. (AUPH) employee data is sourced from the annual SEC 10-K filing. As of 2025, Aurinia Pharmaceuticals Inc. had 128 full-time employees globally. Full-time employees only. Global consolidated headcount.

Aurinia Pharmaceuticals Inc. employs 128 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $2.21M, reflecting the company's operational efficiency.

Aurinia Pharmaceuticals Inc.'s workforce decreased by 2 (1.54%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Aurinia Pharmaceuticals Inc.'s revenue per employee of $2.21M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

AUPH Employees · 5 questions

As of the latest SEC 10-K filing (2025), Aurinia Pharmaceuticals Inc. had 128 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Aurinia Pharmaceuticals Inc. employee counthow many employees does Aurinia Pharmaceuticals Inc. haveAUPH total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-26